We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

35 hedge funds and large institutions have $167M invested in ProQR Therapeutics in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

36% more capital invested

Capital invested by funds: $123M → $167M (+$44.1M)

17% more funds holding

Funds holding: 30 → 35 (+5)

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
11
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$13.3M
2
PC
PointState Capital
New York
+$2.63M
3
VAM
Visium Asset Management
New York
+$1.71M
4
ClearBridge Investments
ClearBridge Investments
New York
+$1.54M
5
AC
Ascend Capital
California
+$1.37M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$9.44M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$3.48M
3
DM
Deerfield Management
New York
-$2.28M
4
SM
Sabby Management
Florida
-$1.95M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$1.27M -$839K -55,259 -49%
Morgan Stanley
27
Morgan Stanley
New York
$901K +$390K +25,726 +162%
PC
28
Polar Capital
United Kingdom
$406K +$285K +18,754 New
CLM
29
ClearBridge LLC (Maryland)
Maryland
$377K +$212K +14,000 +412%
SCM
30
Sterling Capital Management
North Carolina
$318K -$71.5K -4,708 -24%
Deutsche Bank
31
Deutsche Bank
Germany
$245K -$195K -12,830 -53%
Goldman Sachs
32
Goldman Sachs
New York
$244K +$171K +11,270 New
UBS Group
33
UBS Group
Switzerland
$10K +$6.71K +442 New
SM
34
Sabby Management
Florida
$5.48K -$1.95M -128,166 -34%
Bank of America
35
Bank of America
North Carolina
$2K +$1.52K +100 New
BI
36
BVF Inc
California
– -$9.44M -549,000 Closed
Federated Hermes
37
Federated Hermes
Pennsylvania
– -$3.48M -202,500 Closed
Citadel Advisors
38
Citadel Advisors
Florida
– -$1.87M -108,715 Closed
SAM
39
Sectoral Asset Management
Quebec, Canada
– -$1.2M -70,000 Closed
1
2

PRQR Hedge Fund Activity: Q4 2014 in Review

35 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q4 2014, worth a combined $167M — up 36% from $123M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PRQR positions and 4 closed out — a net gain of 5 holders — while 11 added to existing stakes and 11 trimmed.

The largest buyer was OrbiMed, adding an estimated $13.3M. The largest seller was BVF Inc, exiting entirely with an estimated $9.44M sold.

  • 35 institutional investors held ProQR Therapeutics (PRQR) as of Q4 2014, up from 30 in Q3 2014.
  • Funds reported $167M of ProQR Therapeutics stock for Q4 2014, up 36% quarter-over-quarter.
  • 9 funds opened new ProQR Therapeutics positions in Q4 2014 and 4 closed out, a net change of +5 holders.
  • The largest ProQR Therapeutics buyer in Q4 2014 was OrbiMed, an estimated $13.3M added.
  • The largest ProQR Therapeutics seller in Q4 2014 was BVF Inc, an estimated $9.44M sold.

Based on aggregated 13F filings for Q4 2014.